Bayer Schering Gets Positive European Review For Zevalin In Follicular Lymphoma
This article was originally published in The Pink Sheet Daily
Executive Summary
CTI anticipates second-half filing in the U.S., CEO Bianco tells “The Pink Sheet” DAILY.
You may also be interested in...
Broader Zevalin NHL Label: 18 Times More Use?
New indication sought in sBLA could mean whopper sales, CTI exec says.
Broader Zevalin NHL Label: 18 Times More Use?
New indication sought in sBLA could mean whopper sales, CTI exec says.
Zevalin Phase II Data Lift Cell Therapeutics
Company submits Xyotax for lung cancer in Europe.